Cargando…
p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance
Tumor cells with p53 inactivation frequently exhibit chemotherapy resistance, which poses a longstanding challenge to cancer treatment. Here we unveiled a previously unrecognized role of TET2 in mediating p53-loss induced chemotherapy resistance in colon cancer. Deletion of TET2 in p53KO colon cance...
Autores principales: | Zhang, Jixiang, Tan, Peng, Guo, Lei, Gong, Jing, Ma, Jingjing, Li, Jia, Lee, Minjung, Fang, Shaohai, Jing, Ji, Johnson, Gavin, Sun, Deqiang, Cao, Wen-ming, Dashwood, Roderick, Han, Leng, Zhou, Yubin, Dong, Wei-Guo, Huang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419514/ https://www.ncbi.nlm.nih.gov/pubmed/30390073 http://dx.doi.org/10.1038/s41388-018-0524-5 |
Ejemplares similares
-
Engineered
Split-TET2 Enzyme for Inducible Epigenetic Remodeling
por: Lee, Minjung, et al.
Publicado: (2017) -
Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development
por: Fang, Shaohai, et al.
Publicado: (2019) -
TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10
por: Tan, Peng, et al.
Publicado: (2018) -
TRIM59 deficiency curtails breast cancer metastasis through SQSTM1-selective autophagic degradation of PDCD10
por: Tan, Peng, et al.
Publicado: (2019) -
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis
por: Johnson, Gavin S., et al.
Publicado: (2020)